Enzo Biochem Launches Test for Measuring Risk of Colorectal Cancer

News   Apr 12, 2012

 
Enzo Biochem Launches Test for Measuring Risk of Colorectal Cancer
 
 
 
 

RELATED ARTICLES

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

READ MORE

Programming Cells with Computer-like Logic

News

Novel RNA nano-devices in living cells can sense and analyze multiple complex signals for future synthetic diagnostics and therapeutics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE